Matisse Capital’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-65,640
Closed -$994K 171
2023
Q1
$994K Hold
65,640
0.64% 54
2022
Q4
$910K Buy
65,640
+30,000
+84% +$423K 0.81% 50
2022
Q3
$485K Hold
35,640
0.62% 53
2022
Q2
$522K Buy
+35,640
New +$550K 0.5% 65

Other funds holding BCAT

Matisse Capital's BCAT Position: Q2 2023 in Review

Matisse Capital sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q2 2023, closing a stake of 65,640 shares — an estimated $994K sold.

Matisse Capital first reported a position in BCAT in Q2 2022 and held it in 4 quarters. The position peaked at $994K in Q1 2023. 72 funds tracked by Wall St. Rank hold BCAT as of Q2 2023.

  • Matisse Capital reported no remaining BlackRock Capital Allocation Term Trust position as of Q2 2023 after selling out during the quarter.
  • Matisse Capital sold 65,640 BlackRock Capital Allocation Term Trust shares in Q2 2023, an estimated $994K.
  • Matisse Capital first reported a position in BlackRock Capital Allocation Term Trust in Q2 2022 and held it in 4 quarters.
  • Matisse Capital's BlackRock Capital Allocation Term Trust position peaked at $994K in Q1 2023.
  • 72 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2023.

Based on Matisse Capital's 13F filing for Q2 2023, filed 2 Aug 2023.